Why Moderna and BioNTech Were Winners Today
Both Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) benefited Tuesday from a timely reminder that the coronavirus pandemic isn't yet over, and certain patient populations remain vulnerable.
The stocks of the two companies rose on the Food and Drug Administration (FDA) amending its authorizations for the pair's COVID vaccines. Moderna enjoyed a nearly 4.4% boost to its share price, while BioNTech closed the day 3.6% higher.
Image source: Getty Images.
Source Fool.com
